Pinafide
Pinafide is an orally active anticancer agent. Pinafide binds to double-stranded DNA via intercalation, stabilizes the DNA-topoisomerase II complex, induces photo-induced DNA damage and ROS production, causes lysosomal and mitochondrial dysfunction, impairs DNA and RNA synthesis, and blocks cell growth. Pinafide binds to human serum albumin in vitro, undergoes biotransformation via reduction and acetylation in rats, and can cross the placental barrier of pregnant rats. Pinafide can be used in cancer-related research such as hepatocellular carcinoma.
For research use only. We do not sell to patients.
- CAS No.: 54824-20-3
- Formula: C18H17N3O4
- Molecular Weight:339.35
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All DNA/RNA Synthesis Isoforms
More
Biological Activity
Description
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HepG2 | IC50 |
1.23 μM
|
Antiproliferative activity against human hepatocellular carcinoma HepG2 cells assessed as inhibition of cell growth by MTT tetrazolium dye assay.
Antiproliferative activity against human hepatocellular carcinoma HepG2 cells assessed as inhibition of cell growth by MTT tetrazolium dye assay.
|
33803403 |
In Vitro
Pinafide (10-50 μg/mL) binds to human serum albumin, with one high-affinity, low-binding-capacity site (K1 = 2.8×106 M-1) and one moderate-affinity, high-binding-capacity site (K2 = 5.3×103 M-1)[1].
Pinafide is a classic DNA intercalator that stabilizes calf thymus DNA, with a ΔTm of 6.50 °C and a binding constant of 6.60 × 104 M-1[2].
Pinafide potently inhibits the proliferation of human hepatocellular carcinoma HepG2 cells, with an IC50 value of 1.23 μM; when applied at the IC50 concentration of 1.23 μM, it induces G2/M phase cell cycle arrest in human hepatocellular carcinoma HepG2 cells[2].
Pinafide (0.615 μM; 24 h) induces reactive oxygen species production in human hepatocellular carcinoma HepG2 cells[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
Pinafide (10 mg/kg; i.v.; single bolus) crosses the placental barrier in pregnant Sprague-Dawley rats, with fetus and amniotic fluid concentrations exceeding or matching maternal blood concentrations 1 hour after i.v. administration[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 54824-20-3
-
Molecular Weight 339.35
-
Formula C18H17N3O4
-
SMILES
O=C1C2=C3C(C(N1CCN4CCCC4)=O)=CC([N+]([O-])=O)=CC3=CC=C2
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)